Alterations in Gene Can Prevent Non-Inheritable Parkinson's Disease and Dementia

Functional changes in an immune regulating gene can prevent Parkinson's disease (PD) and dementia, revealed a new study.

Research team at University of Copenhagen, Denmark, has discovered that non-inheritable Parkinson's disease may be caused by functional changes in the immune regulating gene Interferon-beta (IFNbeta). Treatment with IFNbeta-gene therapy successfully prevented neuronal death and disease effects in an experimental model of PD. The results have just been published in prestigious scientific journal Cell.

Scientists Discover New Gene Involved in Parkinson's Disease
A new gene involved in Parkinson's disease, a finding that may one day provide a target for a new drug to prevent and potentially even cure the debilitating neurological disorder.

The human brain consists of approximately 100 billion neurons, which coordinate activities in all parts of the body. The group of Professor Shohreh Issazadeh-Navikas has discovered that the immune gene IFNbeta plays a vital role in keeping neurons healthy.

Researchers found that IFNbeta is essential for neurons ability to recycle waste proteins. Without this, the waste proteins accumulate in disease-associated structures called Lewy bodies and with time the neurons die, explains first author Patrick Ejlerskov.

The research team found that mice missing IFNbeta developed Lewy bodies in parts of the brain, which control body movement and restoration of memory, and as a result they developed disease and clinical signs similar to patients with PD and dementia with Lewy bodies (DLB).

L-DOPA Therapy for Angelman Syndrome Have Positive and Negative Effects
A clinical trial of L-DOPA -- a mainstay of Parkinson's disease therapy -- was launched last year for Angelman syndrome.

"Our hope is that this knowledge will enable development of more effective treatment of PD," says Professor Shohreh Issazadeh-Navikas.

Source-ANI

Alzheimer Disease and Parkinson Disease Do Not Appear To Share Common Genetic Risk: Study
The genetic overlap between Parkinson disease (PD) and Alzheimer disease (AD) were examined by a study.

Cerebrospinal Fluid Biomarkers Examined in Early Parkinson Disease
In a group of untreated patients compared with healthy patients, cerebrospinal fluid (CSF) levels of tau proteins, ɑ-synuclein, and β-amyloid 1-42 (Αβ1-42) appear to be associated with early stage Parkinson disease.